Man speaking with healthcare workers

Integrating the Patient Voice

The patient experience encompasses far more than the endpoints and outcomes that are typically measured by clinical trials. Patients want to know whether a treatment – or a trial — will improve their quality of life and not impose an undue burden on their daily routine. 

In fact, the patient perspective is now recognized as an integral part of designing and executing studies that deliver real-world value for patients.  

At PPD, four core components distinguish us as leaders in capturing the patient voice and applying it to the successful design and execution of your study.

  1. Patient insights
  2. Patient modeling
  3. Patient data
  4. Patient diversity

In 2019, PPD received Medidata’s first-ever Patient First Award, which recognizes a company for trailblazing technology that decreases the patient burden in clinical trials.

We ask and answer relevant patient questions that influence study outcomes

  • Do your inclusion/exclusion criteria represent a true patient population that exists in reality and not in theory?
  • Are your endpoints relevant and meaningful to patients and their quality of life?
  • Is your study schedule, dosing regimen and route of administration manageable for your patient population?
  • What will the FDA require from an approval perspective, and how will those requirements impact recruitment and retention?
  • What is your product’s risk-benefit ratio, and how do you position this message in the market place?

Patient surveys

We instantly connect with patients through our fully-identified patient database of 100 million households, to gather insights, perspectives and experiences before your trial begins

  • Our patient surveys cover conditions, including NASH, NAFLD, CVD, diabetes, cancer, arthritis, endometriosis, etc.
Patient advocacy groups We develop strategic collaborations with advocacy groups across many indications to better understand patient perspectives, motivations and barriers to trial participation at large and with regard to your specific protocol. In addition, our PPD Heroes program nurtures ongoing relationships with patients and caregivers who share their stories as a means of inspiring others to participate in clinical research.
Diversity and inclusion We use a multicultural lens to interpret the varied perspectives of patients whose age, gender, ethnicity, race, and culture shape their perceptions of healthcare and clinical research. These learnings ensure a patient-centered experience by viewing the scientific, regulatory and logistical aspects through the eyes of the patient, while allowing us to anticipate and overcome obstacles to recruitment and retention.
Feasibility assessments Our dedicated patient centered research team conducts extensive patient research, feasibility assessments, and other qualitative and quantitative research to fully understand the motivations and challenges related to your respective indication, protocol design and patient population.
Technology to model outcomes We use electronic clinical outcome assessments (eCOA), augmented by Medidata’s platform, to measure the patient burden associated with a specific study design and reduce the burden to make the study more feasible. In addition, the platform enables immediate access to patient data in a single system in order to stage dosing and monitor the patient’s condition for improved disease management.

Complete the form below to connect with us.

Featured resources